{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:28:46Z","timestamp":1792783726103,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ricerca Finalizzata GR Familia","award":["2011-02351489"],"award-info":[{"award-number":["2011-02351489"]}]},{"name":"Ricerca Corrente"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.beem.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T01:00:58Z","timestamp":1542675658000},"page":"891-908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Molecular pathogenesis of parathyroid tumours"],"prefix":"10.1016","volume":"32","author":[{"given":"Luigia","family":"Cinque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Stefano","family":"Salcuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Guarnieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.11.001_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.11.001_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"3","author":"Thakker","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib3","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"12","author":"Brandi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/BF03345303","article-title":"Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics","volume":"11","author":"Scarpelli","year":"2004","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2018.11.001_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0002-9343(87)90008-8","article-title":"Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1","volume":"4","author":"Benson","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.11.001_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2796.1998.00275.x","article-title":"Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1","volume":"6","author":"Burgess","year":"1998","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.11.001_bib7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"12","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.11.001_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cen.12714","article-title":"Prevalence of 6 parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 \u2013 case reportand review of the literature","volume":"2","author":"Singh Ospina","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","article-title":"Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature","volume":"31","author":"Christakis","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.beem.2018.11.001_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/ol.2017.6162","article-title":"Novel association of MEN1 gene mutations with parathyroid carcinoma","volume":"1","author":"Cinque","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.beem.2018.11.001_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"5311","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.beem.2018.11.001_bib12","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1210\/jc.2011-0241","article-title":"Menin missense mutants encoded by the MEN1 gene that are targeted to the proteasome: restoration of expression and activity by CHIP siRNA","volume":"2","author":"Canaff","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib13","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddt039","article-title":"Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study","volume":"10","author":"Thevenon","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2018.11.001_bib14","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1038\/sj.onc.1209400","article-title":"Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression","volume":"25","author":"La","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2018.11.001_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"4","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.beem.2018.11.001_bib16","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1073\/pnas.0503484102","article-title":"Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c","volume":"41","author":"Karnik","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.11.001_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1073\/pnas.0408836102","article-title":"Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors","volume":"3","author":"Milne","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.11.001_bib18","doi-asserted-by":"crossref","first-page":"T147","DOI":"10.1530\/ERC-17-0298","article-title":"Epigenetic regulation by the menin pathway","volume":"10","author":"Feng","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2018.11.001_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/0008-5472.CAN-16-1567","article-title":"Menin and Daxx interact to suppress neuroendocrine tumors through epigenetic control of the membrane metallo-endopeptidase","volume":"2","author":"Feng","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/1541-7786.MCR-13-0170","article-title":"Menin directly represses Gli1 expression independent of canonical Hedgehog signaling","volume":"10","author":"Gurung","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib21","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1158\/0008-5472.CAN-12-3158","article-title":"Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome","volume":"8","author":"Gurung","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib22","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1038\/sj.onc.1204529","article-title":"The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation","volume":"36","author":"Heppner","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2018.11.001_bib23","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1073\/pnas.061358098","article-title":"Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling","volume":"7","author":"Kaji","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.11.001_bib24","doi-asserted-by":"crossref","first-page":"40267","DOI":"10.1074\/jbc.M401312200","article-title":"Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2","volume":"39","author":"Sowa","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.11.001_bib25","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1158\/0008-5472.CAN-06-0061","article-title":"Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response","volume":"17","author":"Busygina","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib26","doi-asserted-by":"crossref","first-page":"15278","DOI":"10.1038\/ncomms15278","article-title":"Menin enhances c-Myc-mediated transcription to promote cancer progression","volume":"8","author":"Wu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2018.11.001_bib27","first-page":"6135","article-title":"Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex","volume":"19","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/MCB.23.2.493-509.2003","article-title":"The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene","volume":"2","author":"Sukhodolets","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.beem.2018.11.001_bib29","first-page":"4204","article-title":"Menin associates with FANCD2, a protein involved in repair of DNA damage","volume":"14","author":"Jin","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib30","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1158\/0008-5472.CAN-04-0724","article-title":"Functional interaction between tumor suppressor menin and activator of S-phase kinase","volume":"18","author":"Schnepp","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib31","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jc.2003-030288","article-title":"Transcription regulation of the multiple endocrine neoplasia type 1 gene in human and mouse","volume":"8","author":"Zablewska","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib32","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1074\/jbc.M112.341958","article-title":"Impaired transforming growth factor-\u03b2 (TGF-\u03b2) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1)","volume":"11","author":"Canaff","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.11.001_bib33","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1158\/1541-7786.MCR-07-2206","article-title":"Menin promotes the Wnt signaling pathway in pancreatic endocrine cells","volume":"12","author":"Chen","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/en.2011-1460","article-title":"Glucose-mediated repression of menin promotes pancreatic \u03b2-cell proliferation","volume":"2","author":"Zhang","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2018.11.001_bib35","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1152\/ajpendo.00542.2013","article-title":"miR-24 regulates menin in the endocrine pancreas","volume":"1","author":"Vijayaraghavan","year":"2014","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/1541-7786.MCR-06-0123","article-title":"Phosphorylation of the menin tumor suppressor protein on serine 543 and serine 583","volume":"10","author":"MacConaill","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib37","article-title":"The menin tumor suppressor protein is phosphorylated in response to DNA damage","volume":"1","author":"Francis","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2018.11.001_bib38","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-2796.2003.01168.x","article-title":"Hyperparathyroidism-jaw tumour syndrome","volume":"253","author":"Chen","year":"2003","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.11.001_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","article-title":"Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome","volume":"257","author":"Bradley","year":"2005","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.11.001_bib40","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.11.001_bib41","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.11.001_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/his.13306","article-title":"Heritable forms of primary hyperparathyroidism: a current perspective","volume":"72","author":"DeLellis","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.beem.2018.11.001_bib43","first-page":"805","article-title":"Familial hyperparathyroidism - disorders of growth and secretion in hormone-secretory tissue","volume":"11","author":"Marx","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2018.11.001_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"3","author":"Newey","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.11.001_bib45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/gcc.20911","article-title":"Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family","volume":"50","author":"Casc\u00f3n","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beem.2018.11.001_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.2011.04184.x","article-title":"Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism","volume":"76","author":"Domingues","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib47","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib48","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1210\/jc.2014-1481","article-title":"CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma","volume":"99","author":"Korpi-Hy\u00f6v\u00e4lti","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/cen.12461","article-title":"Familial isolated primary hyperparathyroidism\/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese","volume":"81","author":"Kong","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib50","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.surg.2014.08.004","article-title":"Hyperparathyroidism-jaw tumor syndrome: results of operative management","volume":"6","author":"Mehta","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.11.001_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MPH.0000000000000443","article-title":"Parathyroid cancer in the pediatric patient","volume":"38","author":"Davidson","year":"2016","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.beem.2018.11.001_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12881-017-0459-7","article-title":"Erratum to: large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family","volume":"18","author":"Guarnieri","year":"2017","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.beem.2018.11.001_bib53","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/js.2016-1089","article-title":"Hyperparathyroidism-jaw tumor syndrome associated with large-scale 1q31 deletion","volume":"1","author":"Rubinstein","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.beem.2018.11.001_bib54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/EC-17-0126","article-title":"Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome","volume":"6","author":"Mamedova","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2018.11.001_bib55","first-page":"20721","article-title":"Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion","volume":"29","author":"Muscarella","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.beem.2018.11.001_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082292","article-title":"Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene","volume":"8","author":"Pazienza","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2018.11.001_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097994","article-title":"Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization","volume":"9","author":"Masi","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2018.11.001_bib58","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/000348940711601210","article-title":"Aberrant methylation of the HRPT2 gene in parathyroid carcinoma","volume":"12","author":"Hewitt","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.beem.2018.11.001_bib59","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","article-title":"The parafibromin tumor suppressor protein is part of a human Paf1 complex","volume":"2","author":"Rozenblatt-Rosen","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.beem.2018.11.001_bib60","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1101\/gad.1292105","article-title":"The human PAF complex coordinates transcription with events downstream of RNA synthesis","volume":"19","author":"Zhu","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.beem.2018.11.001_bib61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2796.2009.02107.x","article-title":"Parafibromin--functional insights","volume":"1","author":"Newey","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.11.001_bib62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","article-title":"Parafibromin\/Hyrax activates Wnt\/Wg target gene transcription by direct association with beta-catenin\/Armadillo","volume":"2","author":"Mosimann","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.beem.2018.11.001_bib63","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.1073\/pnas.0710725105","article-title":"The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-mycprotooncogene","volume":"105","author":"Lin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.11.001_bib64","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1128\/MCB.00654-07","article-title":"Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice","volume":"9","author":"Wang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.beem.2018.11.001_bib65","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/sj.onc.1210445","article-title":"Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen","volume":"42","author":"Iwata","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2018.11.001_bib66","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","article-title":"Nucleolar localization of parafibromin is mediated by three nucleolar localization signals","volume":"26","author":"Hahn","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.beem.2018.11.001_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1541-7786.MCR-06-0129","article-title":"Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function","volume":"2","author":"Lin","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib68","doi-asserted-by":"crossref","first-page":"22429","DOI":"10.1074\/jbc.R600015200","article-title":"Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors","volume":"32","author":"Gordon","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.11.001_bib69","article-title":"Wnt signaling in cancer","volume":"5","author":"Polakis","year":"2012","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.beem.2018.11.001_bib70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1476-4598-9-294","article-title":"Aberrant WNT\/\u03b2-catenin signaling in parathyroid carcinoma","volume":"9","author":"Svedlund","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.beem.2018.11.001_bib71","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.mod.2009.02.002","article-title":"The role of Parafibromin\/Hyrax as a nuclear Gli\/Ci-interacting protein in Hedgehog target gene control","volume":"5\u20136","author":"Mosimann","year":"2009","journal-title":"Mech Dev"},{"key":"10.1016\/j.beem.2018.11.001_bib72","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1038\/ncomms12887","article-title":"Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt\/Hedgehog\/Notch pathways","volume":"7","author":"Kikuchi","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2018.11.001_bib73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35018111","article-title":"Genetic ablation of parathyroid glands reveals another source of parathyroid hormone","volume":"406","author":"G\u00fcnther","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.beem.2018.11.001_bib74","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1074\/jbc.275.7.4774","article-title":"Protein stability and domain topology determine the transcriptional activity of the mammalian glial cells missing homolog, GCMb","volume":"275","author":"Tuerk","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.11.001_bib75","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI200113180","article-title":"Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB","volume":"108","author":"Ding","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.11.001_bib76","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/hmg\/ddq084","article-title":"Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism","volume":"19","author":"Bowl","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2018.11.001_bib77","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(98)01650-0","article-title":"Isolation and expression analysis of a novel human homologue of the Drosophila glial cells missing (gcm) gene","volume":"442","author":"Kanemura","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.beem.2018.11.001_bib78","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ydbio.2005.06.026","article-title":"Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1","volume":"285","author":"Ivins","year":"2005","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2018.11.001_bib79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/dbio.2001.0283","article-title":"Tbx1, a Di George syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development","volume":"235","author":"Garg","year":"2001","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2018.11.001_bib80","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI42021","article-title":"Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2","volume":"120","author":"Grigorieva","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.11.001_bib81","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1359\/jbmr.090211","article-title":"Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells","volume":"24","author":"Mizobuchi","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.11.001_bib82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/humu.20827","article-title":"Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism","volume":"30","author":"Canaff","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.11.001_bib83","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1210\/jc.2009-2532","article-title":"A\u00a0missense glial cells missing homolog B (GCMB) mutation, Asn502His, causes autosomal dominant hypoparathyroidism","volume":"95","author":"Mirczuk","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib84","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2011.04256.x","article-title":"Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism","volume":"76","author":"Yi","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib85","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.2004.026898","article-title":"Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism","volume":"42","author":"Baumber","year":"2005","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.beem.2018.11.001_bib86","doi-asserted-by":"crossref","first-page":"E2421","DOI":"10.1210\/jc.2014-2174","article-title":"Comprehensive next-generation sequencing analyses of hypoparathyroidism: identification of novel GCM2 mutations","volume":"99","author":"Mitsui","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib87","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/jpem-2012-0080","article-title":"A\u00a0novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism","volume":"25","author":"Doyle","year":"2012","journal-title":"J\u00a0Pediatr Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib88","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.93.25.14912","article-title":"The gcm-motif: a novel DNA-binding motif conserved in Drosophila and mammals","volume":"93","author":"Akiyama","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.11.001_bib89","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1073\/pnas.94.9.4739","article-title":"The regulator of early gliogenesis glial cells missing is a transcription factor with a novel type of DNA-binding domain","volume":"94","author":"Schreiber","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.11.001_bib90","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/nar\/26.10.2337","article-title":"Structural requirements for DNA binding of GCM proteins","volume":"26","author":"Schreiber","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.beem.2018.11.001_bib91","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-Activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.11.001_bib92","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.surg.2004.06.056","article-title":"GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism","volume":"136","author":"Kebebew","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.11.001_bib93","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2002.01627.x","article-title":"Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism","volume":"57","author":"Correa","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/JOE-10-0247","article-title":"Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism","volume":"210","author":"Mannstadt","year":"2011","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib95","doi-asserted-by":"crossref","first-page":"E2794","DOI":"10.1210\/jc.2014-2857","article-title":"Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts","volume":"99","author":"D'Agruma","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib96","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biopha.2017.05.028","article-title":"Specifying the molecular pattern of sporadic parathyroid tumorigenesis-The Y282D variant of the GCM2 gene","volume":"92","author":"Marchiori","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.beem.2018.11.001_bib97","first-page":"781","article-title":"Multiple endocrine neoplasia syndromes associated with mutation of p27","volume":"9","author":"Lee","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2018.11.001_bib98","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"10","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.beem.2018.11.001_bib99","doi-asserted-by":"crossref","first-page":"S1428","DOI":"10.1245\/s10434-014-4351-9","article-title":"Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors","volume":"22","author":"Crona","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2018.11.001_bib100","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood.V86.5.1924.bloodjournal8651924","article-title":"Alterations of the p27KIP1 gene in non-Hodgkin\u2019s lymphomas and adult T-cell leukemia\/lymphoma","volume":"5","author":"Morosetti","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beem.2018.11.001_bib101","first-page":"2400","article-title":"p27\/Kip1 mutation found in breast cancer","volume":"10","author":"Spirin","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2018.11.001_bib102","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1093\/emboj\/20.23.6672","article-title":"p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis","volume":"23","author":"Rodier","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.beem.2018.11.001_bib103","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7624798","article-title":"Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27","volume":"5224","author":"Pagano","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.beem.2018.11.001_bib104","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm0297-231","article-title":"Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas","volume":"2","author":"Loda","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.beem.2018.11.001_bib105","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1210\/endo-119-4-1618","article-title":"Tissue and gene specific hypomethylation of the human parathyroid hormone gene: association with parathyroid hormone gene expression in parathyroid glands","volume":"119","author":"Levine","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2018.11.001_bib106","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jc.2005-2095","article-title":"Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene","volume":"2","author":"VanHouten","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib107","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1877-1173(09)89003-0","article-title":"Calcium-sensing receptor and associated diseases","volume":"89","author":"Hendy","year":"2009","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.beem.2018.11.001_bib108","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1074\/jbc.275.11.7553","article-title":"Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas","volume":"275","author":"Chikatsu","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.11.001_bib109","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/carcin\/bgs338","article-title":"The calcium sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1\/2-dependent apoptosis","volume":"34","author":"Casal\u00e0","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.beem.2018.11.001_bib110","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/modpathol.2011.10","article-title":"Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis","volume":"24","author":"Hizaki","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2018.11.001_bib111","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4161\/epi.24823","article-title":"Global and gene-specific promoter methylation analysis in primary hyperparathyroidism","volume":"8","author":"Sulaiman","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.beem.2018.11.001_bib112","doi-asserted-by":"crossref","first-page":"E1307","DOI":"10.1210\/jc.2011-3136","article-title":"Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification","volume":"97","author":"Svedlund","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib113","doi-asserted-by":"crossref","first-page":"e9472","DOI":"10.1371\/journal.pone.0009472","article-title":"Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours","volume":"5","author":"Juhlin","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2018.11.001_bib114","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2017.05.010","article-title":"Alterations of DNA methylation in parathyroid tumors","volume":"469","author":"Guarnieri","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib115","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of somatic mutations in parathyroid tumors using whole-exome sequencing","volume":"97","author":"Cromer","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib116","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12020-016-0892-y","article-title":"EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms","volume":"54","author":"Sanpaolo","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.11.001_bib117","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/ERC-13-0497","article-title":"The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors","volume":"21","author":"Svedlund","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2018.11.001_bib118","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0039-6060(03)00422-7","article-title":"Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas","volume":"134","author":"Carling","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.11.001_bib119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2016.10.035","article-title":"MicroRNAs in parathyroid physiopathology","volume":"456","author":"Vaira","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/JME-11-0189","article-title":"The microRNA cluster C19MC is deregulated in parathyroid tumours","volume":"2","author":"Vaira","year":"2012","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.beem.2018.11.001_bib121","first-page":"1070","article-title":"Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up","volume":"6","author":"Howe","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.11.001_bib122","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"6428","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.beem.2018.11.001_bib123","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0959-4388(99)00048-3","article-title":"The GDNF family ligands and receptors - implications for neural development","volume":"1","author":"Baloh","year":"2000","journal-title":"Curr Opin Neurobiol"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2018.11.001_bib124","doi-asserted-by":"crossref","first-page":"69","DOI":"10.6061\/clinics\/2012(Sup01)13","article-title":"Genotype-phenotype correlation in multiple endocrine neoplasia type 2","volume":"67","author":"Raue","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.beem.2018.11.001_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-7-53","article-title":"Stabilizing mutation of CTNNB1\/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients","volume":"7","author":"Bj\u00f6rklund","year":"2008","journal-title":"Mol Cancer"},{"key":"10.1016\/j.beem.2018.11.001_bib126","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12020-012-9690-3","article-title":"Evidence of a stabilizing mutation of \u03b2-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas","volume":"3","author":"Starker","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.11.001_bib127","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1210\/jc.2006-2554","article-title":"Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas","volume":"4","author":"Costa-Guda","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12020-011-9558-y","article-title":"A\u00a0rare S33C mutation of CTNNB1 encoding \u03b2-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort","volume":"1","author":"Guarnieri","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.11.001_bib129","doi-asserted-by":"crossref","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","article-title":"Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas","volume":"10","author":"Newey","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.4203","article-title":"Complete genomic landscape of a recurring sporadic parathyroid carcinoma","volume":"3","author":"Kasaian","year":"2013","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.beem.2018.11.001_bib131","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion","volume":"2","author":"Yu","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.11.001_bib132","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"6","author":"Pandya","year":"2017","journal-title":"J\u00a0Clin Invest Insight"},{"key":"10.1016\/j.beem.2018.11.001_bib133","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1210\/en.2018-00246","article-title":"Whole-exome sequencing identifies novel recurrent somatic mutations in sporadic parathyroid adenomas","volume":"8","author":"Wei","year":"2018","journal-title":"Endocrinology"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:54:56Z","timestamp":1761497696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18301295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":133,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1521690X18301295"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.11.001","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular pathogenesis of parathyroid tumours","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}